Skip to Main Content

Paper Details

Biomarkers of platelet activation and cardiovascular risk in the DAPT trial.
J Thromb Thrombolysis
9
2021
CD-40 ligand, CV death, DAPT, MACE, MI, MRP-8/14, P-selectin, VASP, ischemic stroke, myeloid-related protein (MRP)-8/14, patients, platelet, sCD40L
Author NameAffiliation
Robert W YehSmith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School
Laura Mauri
David A MorrowBrigham and Women's Hospital, Harvard Medical School
David A MorrowBrigham and Women's Hospital, Harvard Medical School
Marc S SabatineBrigham and Women's Hospital, Harvard Medical School
Marc S SabatineBrigham and Women's Hospital, Harvard Medical School
  • 1 - 6

Datasets

Release 1.2